Neogen (NEOG) Change in Accured Expenses (2010 - 2026)
Neogen (NEOG) recorded quarterly Change in Accured Expenses of -$7.5 million in Q1 2026, up 47.01% quarter-over-quarter from -$14.2 million in Q4 2025, and down 227.93% on a YoY basis from $5.9 million in Q1 2025.
Neogen (NEOG) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Neogen's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$7.5 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 227.93% year-over-year to -$7.5 million; the TTM figure through Feb 2026 stood at -$13.5 million (down 726.12% YoY), while the FY2025 annual figure was $93000.0, down 99.32% from the prior year.
- Change in Accured Expenses was -$7.5 million for Q1 2026 at Neogen, up from -$14.2 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $37.4 million in Q4 2022 to a low of -$20.7 million in Q1 2023.
- Historically, Change in Accured Expenses has averaged $2.8 million across 5 years, with a median of -$6500.0 in 2025.
- Biggest YoY gain for Change in Accured Expenses was 1468.65% in 2022; the steepest drop was 457.2% in 2022.
- A 5-year view of Change in Accured Expenses shows it stood at $37.4 million in 2022, then tumbled by 79.81% to $7.5 million in 2023, then fell by 0.13% to $7.5 million in 2024, then slumped by 288.79% to -$14.2 million in 2025, then soared by 47.01% to -$7.5 million in 2026.
- The last three Change in Accured Expenses figures came in at -$7.5 million (Q1 2026), -$14.2 million (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | -7.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7.54 Mn |
| Feb 28, 2026 | -7.54 Mn |
| Nov 30, 2025 | -14.23 Mn |
| Nov 30, 2025 | -14.23 Mn |
| Aug 31, 2025 | 14.17 Mn |
| Aug 31, 2025 | 14.17 Mn |
| May 31, 2025 | -5.91 Mn |
| May 31, 2025 | -5.91 Mn |
| Feb 28, 2025 | 5.89 Mn |
| Feb 28, 2025 | 5.89 Mn |
| Nov 30, 2024 | 7.54 Mn |
| Nov 30, 2024 | 7.54 Mn |
| Aug 31, 2024 | -7.43 Mn |
| Aug 31, 2024 | -7.43 Mn |
| May 31, 2024 | -7.64 Mn |
| May 31, 2024 | -7.64 Mn |
| Feb 29, 2024 | 21.55 Mn |
| Feb 29, 2024 | 21.55 Mn |
| Nov 30, 2023 | 7.55 Mn |
| Nov 30, 2023 | 7.55 Mn |